Hypomyelination neuropathy-arthrogryposis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2680OMIM:618186Q68.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hypomyelination neuropathy-arthrogryposis syndrome is an extremely rare condition that affects both the nervous system and the joints. The name describes its two main features: hypomyelination, which means the protective covering (myelin) around nerves does not develop properly, and arthrogryposis, which refers to joints that are stiff and locked in fixed positions from birth. Myelin is like insulation around electrical wires — without it, nerve signals cannot travel properly to the muscles. This leads to severe muscle weakness and poor muscle tone (hypotonia) from birth. Babies born with this condition typically have multiple joint contractures, meaning their arms, legs, and other joints are bent or extended in fixed positions and are difficult to move. Because the nerves that control muscles are not working properly due to the lack of myelin, affected infants have significant difficulty with movement, breathing, and feeding. The condition is present at birth and is often life-threatening in the newborn period. There is currently no cure for this syndrome. Treatment is supportive and focuses on managing symptoms such as breathing difficulties, feeding problems, and joint stiffness. Physical therapy may be used to try to improve joint mobility. Because this condition is so rare, research is very limited, and the treatment landscape remains largely focused on comfort and supportive care.

Key symptoms:

Stiff, locked joints at birth (arthrogryposis)Severe muscle weaknessVery low muscle tone (floppy baby)Breathing difficultiesFeeding difficultiesReduced or absent reflexesPoor nerve function in arms and legsLimited movement of limbsThin or underdeveloped musclesClubfoot or other foot deformitiesFailure to thriveDelayed or absent motor development

Clinical phenotype terms (5)— hover any for plain English
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hypomyelination neuropathy-arthrogryposis syndrome.

View clinical trials →

No actively recruiting trials found for Hypomyelination neuropathy-arthrogryposis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypomyelination neuropathy-arthrogryposis syndrome community →

No specialists are currently listed for Hypomyelination neuropathy-arthrogryposis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypomyelination neuropathy-arthrogryposis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypomyelination neuropathy-arthrogryposis syndromeForum →

No community posts yet. Be the first to share your experience with Hypomyelination neuropathy-arthrogryposis syndrome.

Start the conversation →

Latest news about Hypomyelination neuropathy-arthrogryposis syndrome

No recent news articles for Hypomyelination neuropathy-arthrogryposis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the expected course of this condition for my child specifically?,What breathing and feeding support will my child need, and for how long?,Are there any genetic tests that can confirm the exact cause of this condition?,What therapies are available to help with joint stiffness and mobility?,Is there a risk of this condition occurring again in future pregnancies?,Are there any clinical trials or research studies we could participate in?,What palliative or comfort care options are available if needed?

Common questions about Hypomyelination neuropathy-arthrogryposis syndrome

What is Hypomyelination neuropathy-arthrogryposis syndrome?

Hypomyelination neuropathy-arthrogryposis syndrome is an extremely rare condition that affects both the nervous system and the joints. The name describes its two main features: hypomyelination, which means the protective covering (myelin) around nerves does not develop properly, and arthrogryposis, which refers to joints that are stiff and locked in fixed positions from birth. Myelin is like insulation around electrical wires — without it, nerve signals cannot travel properly to the muscles. This leads to severe muscle weakness and poor muscle tone (hypotonia) from birth. Babies born with thi

How is Hypomyelination neuropathy-arthrogryposis syndrome inherited?

Hypomyelination neuropathy-arthrogryposis syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hypomyelination neuropathy-arthrogryposis syndrome typically begin?

Typical onset of Hypomyelination neuropathy-arthrogryposis syndrome is neonatal. Age of onset can vary across affected individuals.